These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28569236)

  • 21. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis.
    Gross GN; Berman G; Amar NJ; Caracta CF; Tantry SK
    Ann Allergy Asthma Immunol; 2019 Jun; 122(6):630-638.e3. PubMed ID: 30910440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations.
    Patel P; Salapatek AM; Talluri RS; Tantry SK
    Allergy Asthma Proc; 2018 May; 39(3):224-231. PubMed ID: 29669667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of GSP301 nasal spray in children aged 6 to 11 years with seasonal allergic rhinitis.
    Prenner BM; Amar NJ; Hampel FC; Caracta CF; Wu W
    Ann Allergy Asthma Immunol; 2022 Nov; 129(5):618-626.e2. PubMed ID: 35926824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis.
    Segall N; Prenner B; Lumry W; Caracta CF; Tantry SK
    Allergy Asthma Proc; 2019 Sep; 40(5):301-310. PubMed ID: 31248471
    [No Abstract]   [Full Text] [Related]  

  • 25. Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis.
    Fairchild CJ; Meltzer EO; Roland PS; Wells D; Drake M; Wall GM
    Allergy Asthma Proc; 2007; 28(6):716-23. PubMed ID: 18201438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Yamamoto H; Yamada T; Kubo S; Osawa Y; Kimura Y; Oh M; Susuki D; Takabayashi T; Okamoto M; Fujieda S
    Allergy Asthma Proc; 2010; 31(4):296-303. PubMed ID: 20819319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis.
    Meltzer EO; Blaiss M; Fairchild CJ
    Allergy Asthma Proc; 2011; 32(3):213-20. PubMed ID: 21477426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
    Shah S; Berger W; Lumry W; La Force C; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(6):628-33. PubMed ID: 19930788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
    Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Once Daily Fluticasone Furoate Nasal Spray for Treatment of Irritant (Non-allergic) Rhinitis.
    Tantilipikorn P; Thanaviratananich S; Chusakul S; Benjaponpitak S; Fooanant S; Chintrakarn C; Jirapongsananuruk O; Visitsunthorn N; Toler T; Sutton L; Wu W; Lee L
    Open Respir Med J; 2010 Nov; 4():92-9. PubMed ID: 21253453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
    van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
    Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH; Lieberman P;
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis.
    Maspero JF; Walters RD; Wu W; Philpot EE; Naclerio RM; Fokkens WJ
    Allergy Asthma Proc; 2010; 31(6):483-92. PubMed ID: 21708060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE; White MV;
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.